Constipation

Gastroenterology·MeSH: Constipation

22 drugs in development·16 companies·6 clinical trials

Drug Pipeline by Phase

Approved(14)

Drug	Company
amitiza	SUCAMPO PHARMACEUTICALS, INC. (SCMP)
elobixibat	ALBIREO PHARMA, INC. (ALBO)
Enema Glycerini	China Health Industries Holdings, Inc. (CHHE)
IBSRELA	ARDELYX, INC. (ARDX)
LINZESS	IRONWOOD PHARMACEUTICALS INC (IRWD)
polyethylene glycol 3350	Mylan II B.V. (MYL)
polyethylene glycol 3350	ANI PHARMACEUTICALS INC (ANIP)
polyethylene glycol 3350	Optec International, Inc. (GM)
Relistor	Bausch Health Companies Inc. (BHC)
RELISTOR	Lantheus Holdings, Inc. (LNTH)
symproic	BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
Symproic	COLLEGIUM PHARMACEUTICAL, INC (COLL)
trulance	SYNERGY PHARMACEUTICALS LLC (SGYP)
Trulance	Bausch Health Companies Inc. (BHC)

Phase 3(5)

Drug	Company
Linaclotide	AbbVie Inc. (ABBV)
tenapanor (CIC label extension / ACCEL (ten-03-301))	ARDELYX, INC. (ARDX)
tenapanor 25 mg bid	ARDELYX, INC. (ARDX)
tenapanor 5 mg bid	ARDELYX, INC. (ARDX)
tenapanor 50 mg bid	ARDELYX, INC. (ARDX)

Phase 2(1)

Drug	Company
tenapanor	ARDELYX, INC. (ARDX)

Preclinical(2)

Drug	Company
digestive tract irregularity formulation	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
hydrogel candidates for functional constipation	GELESIS HOLDINGS, INC. (GLS)

BioSniper tracks 22 drugs in development for Constipation across 16 companies.

There are 6 clinical trials targeting Constipation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.